Eamon Brady

CEO at WhiteSwell

Eamon Brady is currently the CEO of WhiteSwell, a company focused on advancing treatment for acute decompensated heart failure. Prior to this, Brady was the CEO and Co-Founder of Neuravi before it was acquired by Johnson & Johnson, where Eamon then served as the CEO of the Neuravi division. With previous experience in companies like Abbott Vascular and MedNova Ltd, Brady has a strong background in R&D and new ventures within the medical industry.

Links

Previous companies

Org chart

Eamon Brady

CEO

Seán Mac Réamoinn

Chief Financial Officer

Andrew Farquharson

Managing Director & Co-founder, Incube Ventures

Andrew Levin

Managing Director, RA Capital

Ann Marie Cannon

VP Quality & Regulatory Affairs

Jill Amstutz

VP Strategic Marketing

Alva Bradley

Professor Of Medicine, Nephrology And Director,

Joann Lindenfeld

Professor Of Medicine, Medical Director

Michael Jonas

Director, Structural Heart Disease, Cardiac Catheterization Services

Martin Keegan

VP Technical Operations

Ronan Keating

VP Research & Development

Suzanne Hansel

Senior Clinical Program Manager

George Bakris

Professor Of Medicine, Nephrology And Director,

Teams

Leadership Team

8 members

Timeline

CEO
July, 2018 - present

Eamon Brady

CEO at WhiteSwell

Org chart

Teams

Leadership Team

Timeline

CEO

Related people

Jennifer Webster

Ashutosh Agrawal

Breahna Beecher, UXC

Scott Wesley Bryant

Grant Stanis